Humoral aspects of polymyositis/dermatomyositis

Area of Science:

• Rheumatology
• Immunology
• Molecular Biology

Background:

• Polymyositis/dermatomyositis (PM/DM) involves systemic autoimmunity.
• Autoantibodies, including myositis-specific antibodies (MSAs), are detected in most PM/DM patients.
• MSAs are linked to specific clinical subgroups, aiding diagnosis and patient classification.

Purpose of the Study:

• To review the role of myositis-specific antibodies (MSAs) in polymyositis/dermatomyositis (PM/DM).
• To discuss the association of MSAs with clinical phenotypes and their diagnostic utility.
• To explore the potential pathogenetic role and etiological insights from understanding MSA production.

Main Methods:

• Review of literature on autoantibodies in PM/DM.
• Characterization of MSAs and their antigens using molecular biology.
• Analysis of associations between MSAs and clinical syndromes like antisynthetase syndrome and PM/DM overlap.

Main Results:

• MSAs are specific to myositis patients and associated with distinct clinical subgroups.
• Antibodies to aminoacyl tRNA synthetases define the antisynthetase syndrome.
• Antibodies to signal recognition particles indicate severe refractory myositis; nuclear antibodies are seen in DM; anti-U1 RNP, anti-U2 RNP, anti-Ku, and anti-PM-Scl are linked to scleroderma-PM overlap.

Conclusions:

• MSAs are valuable diagnostic and classification tools in PM/DM.
• Understanding MSA production mechanisms may offer insights into the etiology of PM/DM.
• The precise role of MSAs in PM/DM pathogenesis remains to be fully elucidated.